(Total Views: 792)
Posted On: 03/15/2021 6:17:42 PM
Post# of 148870
A few comments on CD12 results by Doctors.
2021.03.07 Dr. John Bream, re CD12 results https://www.facebook.com/breammedical/videos/...6747110237
2021.03.08 (11:51) Dr. Harish Seethamraju- In the critically ill population in a well-balanced age group, the outcome of using Leronlimab is phenomenally better than other medications including Dexamethasone. https://www.cytodyn.com/newsroom/press-releas...verview-of
2021.03.08 (14:50) Dr. Mahboob Rahman- There is a benefit in the general population of the trial in all the endpoints. https://www.cytodyn.com/newsroom/press-releas...verview-of
2021.03.10 Dr. Jacob Lalezari to Janet Woodcock (FDA), re CD12 results
https://951217f1-eeef-4b64-88e6-a52aefaa6edc....b761c5.pdf
https://www.questclinical.com/media
2021.03.07 Dr. John Bream, re CD12 results https://www.facebook.com/breammedical/videos/...6747110237
2021.03.08 (11:51) Dr. Harish Seethamraju- In the critically ill population in a well-balanced age group, the outcome of using Leronlimab is phenomenally better than other medications including Dexamethasone. https://www.cytodyn.com/newsroom/press-releas...verview-of
2021.03.08 (14:50) Dr. Mahboob Rahman- There is a benefit in the general population of the trial in all the endpoints. https://www.cytodyn.com/newsroom/press-releas...verview-of
2021.03.10 Dr. Jacob Lalezari to Janet Woodcock (FDA), re CD12 results
https://951217f1-eeef-4b64-88e6-a52aefaa6edc....b761c5.pdf
https://www.questclinical.com/media
(10)
(0)
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
Scroll down for more posts ▼
